| Medicare Wellpoint Federal | Sterilization (59060) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars (59101) | 2026-07-14 |
| Medicare Wellpoint Federal | Off-Label Use of Chemotherapeutic Drugs and Biologicals for Non-Cancer Indications (59217) | 2026-07-14 |
| Medicare Wellpoint Federal | Off-Label Use of Drugs and Biologicals for Anti-Cancer Chemotherapeutic Regimen (59218) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Sacroiliac Joint Injections and Procedures (59233) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin (59311) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Trigger Point Injections (TPI) (59487) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: KidneyIntelX and KidneyIntelX.dkd Testing (59595) | 2026-07-14 |
| Medicare Wellpoint Federal | Pegfilgrastim (Fulphila; Neulasta; Neulasta Onpro; Nyvepria; Udenyca; Ziextenzo) J2506 (59661) | 2026-07-14 |
| Medicare Wellpoint Federal | Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) (59733) | 2026-07-14 |